Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Balluff introduces non-contact, RFID safety guard locking switch June 11, 2018 PTC, Microsoft Bet Cloud-IoT Collab Can Spur Industrial Innovation February 1, 2018 Cognex smart cameras help SYSTEMATIX achieve vision-guided robot bin picking solution July 6, 2018